DRW Securities’s Clearside Biomedical CLSD Stock Holding History

DRW Securities’s Portfolio CLSD Stock Details CLSD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.87K	Hold	27,136	–	–	﹤0.01%	1221
2025 Q4	$19.1K	Buy	+27,136	New	+$95.6K	﹤0.01%	1168
2018 Q2	–	Sell	-1,000	Closed	-$161K	–	110
2018 Q1	$161K	Buy	+1,000	New	+$122K	0.01%	132

DRW Securities's CLSD Position: Q1 2026 in Review

DRW Securities held its Clearside Biomedical (CLSD) position steady in Q1 2026 at 27,136 shares worth $7.87K. The position accounts for ﹤0.01% of the portfolio, ranked #1221.

DRW Securities first reported a position in CLSD in Q1 2018 and has held it in 3 quarters since. The position peaked at $161K in Q1 2018. 1 fund tracked by Wall St. Rank holds CLSD as of Q1 2026.

DRW Securities held 27,136 shares of Clearside Biomedical worth $7.87K as of Q1 2026.
DRW Securities left its Clearside Biomedical share count unchanged in Q1 2026.
Clearside Biomedical made up ﹤0.01% of DRW Securities's portfolio in Q1 2026, its #1221 holding.
DRW Securities first reported a position in Clearside Biomedical in Q1 2018 and has held it in 3 quarters since.
DRW Securities's Clearside Biomedical position peaked at $161K in Q1 2018.
1 fund tracked by Wall St. Rank held Clearside Biomedical as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.